Zydus Life’s North American formulations sales were down 2.6% from last year and up 4.9% sequentially at ₹3,098 crore. The company said the same was driven by sustained volume expansion and new launches.
Zydus Life’s North American formulations sales were down 2.6% from last year and up 4.9% sequentially at ₹3,098 crore. The company said the same was driven by sustained volume expansion and new launches.